UBS AM’s Ardent Health ARDT Stock Holding History

UBS AM’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,822	Closed	-$221K	–	3882
2026 Q1	$221K	Hold	25,822	–	–	﹤0.01%	2714
2025 Q4	$228K	Buy	+25,822	New	+$299K	﹤0.01%	2449

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return

Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's ARDT Position: Q2 2026 in Review

UBS AM sold out of Ardent Health (ARDT) in Q2 2026, closing a stake of 25,822 shares — an estimated $221K sold.

UBS AM first reported a position in ARDT in Q4 2025 and held it in 2 quarters. The position peaked at $228K in Q4 2025. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

UBS AM reported no remaining Ardent Health position as of Q2 2026 after selling out during the quarter.
UBS AM sold 25,822 Ardent Health shares in Q2 2026, an estimated $221K.
UBS AM first reported a position in Ardent Health in Q4 2025 and held it in 2 quarters.
UBS AM's Ardent Health position peaked at $228K in Q4 2025.
138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.